Magazine Article | March 1, 2022

We've Moved Forward

Source: Life Science Leader

By Louis Garguilo, Chief Editor, Outsourced Pharma

We might have expected this CMO Leadership Awards issue to focus heavily on the year 3 CE (Covid Era). But what we’ve discovered is this: We’ve moved forward collectively as an industry, despite the COVID circumstances, to re-enter the broader historicism of the year 2022 regarding our drug development and manufacturing outsourcing strategies and tactics. Don’t get me wrong; we will cover the COVID challenge in this issue, for example, via articles such as, “A Better Path For CMO Relationships As The Pandemic Continues.” More so, though, what you’ll read in these pages is the importance of continuing to advance the knowledge, best practices, and strategies of outsourcing we’ve been covering now for nearly a decade in this issue.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: